Hygieia
United States
- Livonia, Michigan
- 02/05/2023
- Series B
- $22,000,000
Hygieia’s d-Nav® Insulin Management System includes an AI-powered application and helps people with Type 2 diabetes use insulin in a safe and effective way. It works by guiding users to adjust their insulin doses – based on changing blood glucose patterns -- every few days rather than three or four times annually. Studies show that some 90 percent of people using our d-Nav® service achieve lower A1c within three months. Patients tell us they feel better; experience fewer complications; spend less time at their physician’s office; and can lower their disease management costs. The d-Nav® insulin management system was developed by two University of Michigan researchers and has been peer-reviewed with studies published in leading medical journals. Hygieia is headquartered in Livonia, Michigan.
- Industry Medical Equipment Manufacturing
- Website https://d-nav.com/
- LinkedIn https://www.linkedin.com/company/hygieia-inc/
Zócalo Health | $15,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Brev.io | $3,300,000 | (Apr 24, 2026)
Maxed | $850,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
Astor (YC S25) | $5,000,000 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)
Almanac Health | $10,000,000 | (Apr 24, 2026)
Petual | $20,000,000 | (Apr 24, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)